Рет қаралды 3,103
Hear about drugs that have been approved for metastatic breast cancer over the last 2 years and how they impact each subtype of breast cancer. Learn how these latest approvals compare with previous standard-of-care therapies, what we know, and what we don’t, and hear about the exciting drugs and approaches in the pipeline for the next 3 to 5 years.
Featuring Nancy U. Lin, MD, Keynote Speaker at Living Beyond Breast Cancer's 2023 Conference on Metastatic Breast Cancer.
Learn More:
About metastatic breast cancer:
www.lbbc.org/about-breast-can...
About our conference and other sessions:
www.lbbc.org/community/events...
Personal Stories of people living with MBC:
www.lbbc.org/blog?journey=liv...